N8 Foundation Vice President and CEO, Nick Street, was recently selected to participate as a member of the Pediatric Oncology Patient & Caregiver Clinical Trial Advisory Board through Genentech, Inc., a national biotechnology company who focuses on pediatric cancer research. You can learn more about Genentech and its recent projects in pediatric cancer research here.
The Board will hold its first meeting in Washington D.C. on November 12-13, 2015. The purpose of the Board is to help biotechnology companies, such as Genentech, (1) understand the challenges and motivations of pediatric cancer patients (and their parents), (2) better understand how to address their needs in Phase I/II clinical trials, and (3) to discover and define clinical trial services and tools that may be helpful to patients and parents.
UPDATE: The trip/meeting was a success – and quite a learning experience! We even got to take in the sights around the City (for a few hours) before jumping back on the plane and heading back home. Thank you Genentech! Looking forward to all of the promising developments in the future!